Switzerland· 62178001
Avonex Pen
A interferon beta-1a product containing interferonum beta-1a adnr, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Interferon beta-1a is registered in 14 of 19 countries.
Countries holding a registration under ATC L03AB07 (interferon beta-1a), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 9 of them publish a price we can compare per daily dose
Interferon beta-1a · ATC L03AB07
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of interferon beta-1a costs, country by country.
Normalised to the WHO defined daily dose (4.3 mcg), so markets compare like for like.
- Switzerland: $13.13 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Interferon beta-1a · price per daily dose (4.3 mcg)
USD · FX 28 Sept 2026
- CH Switzerland$13.13
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- interferonum beta-1a ADNr
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- L03AB07
- ATC class
- Interferon beta-1a
- Defined daily dose
- 4.3 mcg, P
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin76806217800124 Fertigpen 0.5 mlCHF 909.25
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
347 interactions on record for interferon beta-1a.
Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Interferon beta-1a · interactions on record
347 records
- 15 severe
- 332 moderate
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- ZidovudineJ05AF01severe
- ClotrimazoleA01AB18moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Interferon beta-1a in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAVONEXBiogen Netherlands B.V., Badhoevedorp
- United KingdomAvonex 30microgram powder and solvent for solution for injection vialsBiogen Idec Ltd
- FinlandAvonexBiogen Netherlands B.V.
- BelgiumAvonex 30 µgBiogen Netherlands
- IrelandAVONEX 30 micrograms/0.5 ml solution for injection.Biogen Netherlands B.V.
- SwedenAvonex 30 mikrogram Pulver och vätska till injektionsvätska, lösningBiogen Netherlands B.V.
- FranceAVONEX 30 microgrammes/0,5 ml, solution injectableBIOGEN NETHERLANDS (PAYS-BAS)
- ItalyAVONEX*4 penne preriempite IM 30 mcg/0,5 ml + 4 aghi + 4 cappucci pennaBIOGEN NETHERLANDS B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Avonex, Rebif
- Liechtenstein · Avonex, Rebif
- Norway · Avonex, Rebif
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ad50f822-8aab-4100-b1f4-95d1b675238a GET /v1/drugs/ad50f822-8aab-4100-b1f4-95d1b675238a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "interferonum beta-1a adnr 30 mcg",
"valid_from": "2011-12-01",
"limitations": null,
"galenic_form": "Inj Lös",
"therapeutic_area": null,
"sl_inclusion_date": "2011-12-01",
"self_retention_pct": 10
}See everything about interferon beta-1a.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.